AZD2811
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AZD2811, covering 2025-03-27 to 2025-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Study of AZD2811 + Durvalumab in ES-SCLC [Phase 2]